The hexosamine biosynthetic pathway and O-GlcNAcylation drive the expression of β-catenin and cell proliferation

American Journal of Physiology - Endocrinology and Metabolism

Volumn 302, Issue 4, 2012, Pages

  Olivier Van Stichelen, Stéphanie ^a   Guinez, Céline ^a   Mir, Anne Marie ^a   Perez Cervera, Yobana ^a   Liu, Chunming ^b   Michalski, Jean Claude ^a   Lefebvre, Tony ^a  

^a UNIVERSITÉ DES SCIENCES ET TECHNOLOGIES DE LILLE   (France)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Colorectal cancers; Diet; Glucose; Glutamine:fructose 6 phosphate amidotransferase; Hexosamine biosynthetic pathway; Protooncogene

Indexed keywords

AZASERINE; BETA CATENIN; GLUCOSAMINE; GLUCOSE; HEXOSAMINE; N ACETYLGLUCOSAMINE; WNT PROTEIN;

ACYLATION; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE INTAKE; CARBOHYDRATE SYNTHESIS; CELL PROLIFERATION; CELL STRAIN HCT116; CELL STRAIN HEK293; CELL STRAIN HT29; CELL STRAIN MCF 7; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION;

ACYLATION; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; AZASERINE; BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; COLON; COLORECTAL NEOPLASMS; FASTING; GLUCOSAMINE; GLUCOSE; HUMANS; MALE; MICE; MICE, INBRED C57BL; PROTEIN PROCESSING, POST-TRANSLATIONAL; UP-REGULATION; WNT SIGNALING PATHWAY;

EID: 84863017903     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00390.2011     Document Type: Article

References (37)

1. Anagnostou SH, Shepherd PR. Glucose induces an autocrine activation of the Wnt/_-catenin pathway in macrophage cell lines. Biochem J 416: 211-218, 2008.
2. Ahmed FE. Effect of diet, life style, and other environmental/chemopreventive factors on colorectal cancer development, and assessment of the risks. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 22: 91-147, 2004.
3. Baade PD, Meng X, Youl PH, Aitken JF, Dunn J, Chambers SK. The impact of body mass index and physical activity on mortality among patients with colorectal cancer in Queensland, Australia. Cancer Epidemiol Biomarkers Prev 20: 1410-1420, 2011.
4. Berster JM, Göke B. Type 2 diabetes mellitus as risk factor for colorectal cancer. Arch Physiol Biochem 114: 84-98, 2008.
5. Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol 3: 565-574, 2002.
6. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348: 1625-1638, 2003.
7. Chou TY, Hart GW, Dang CV. c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J Biol Chem 270: 18961-18965, 1995.
8. Dehennaut V, Slomianny MC, Page A, Vercoutter-Edouart AS, Jessus C, Michalski JC, Vilain JP, Bodart JF, Lefebvre T. Identification of structural and functional O-linked N-acetylglucosamine-bearing proteins in Xenopus laevis oocyte. Mol Cell Proteomics 7: 2229-2245, 2008.
9. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
10. Gnagnarella P, Gandini S, La Vecchia C, Maisonneuve P. Glycemic index, glycemic load, and cancer risk: a meta-analysis. Am J Clin Nutr 87: 1793-1801, 2008.
11. Gu Y, Mi W, Ge Y, Liu H, Fan Q, Han C, Yang J, Han F, Lu X, Yu W. GlcNAcylation plays an essential role in breast cancer metastasis. Cancer Res 70: 6344-6351, 2010.
12. Guinez C, Filhoulaud G, Rayah-Benhamed F, Marmie S, Dubuquoy C, Dentin R, Moldes M, Burnol AF, Xang X, Lefebvre T, Girard J, Postic C. O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes 60: 1399-1413, 2011.
13. Hanover JA, Krause MW, Love DC. The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine. Biochim Biophys Acta 1800: 80-95, 2010.
14. Hatsell S, Medina L, Merola J, Haltiwanger R, Cowin P. Plakoglobin is O-glycosylated close to the N-terminal destruction box. J Biol Chem 278: 37745-37752, 2003.
15. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512, 1998.
16. Key TJ, Spencer EA. Carbohydrates and cancer: an overview of the epidemiological evidence. Eur J Clin Nutr 61, Suppl 1: S112-S121, 2007.
17. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study. Cancer Epidemiol Biomarkers Prev 13: 915-919, 2004.
18. Klaus A, Birchmeier W. Wnt signaling and its impact on development and cancer. Nat Rev Cancer 8: 387-398, 2008.
19. Lefebvre T, Baert F, Bodart JF, Flament S, Michalski JC, Vilain JP. Modulation of O-GlcNAc glycosylation during Xenopus oocyte maturation. J Cell Biochem 93: 999-1010, 2004.
20. Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X, He X. Control of beta-catenin phosphorylation/degradation by a dualkinase mechanism. Cell 108: 837-847, 2002.
21. Marshall S, Bacote V, Traxinger RR. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266: 4706-4712, 1991.
22. Mi W, Gu Y, Han C, Liu H, Fan Q, Zhang X, Cong Q, Yu W. O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy. Biochim Biophys Acta 1812: 514-519, 2011.
23. Olivier S, Mir AM, Michalski JC, Lefebvre T. Signaling and metabolic predispositions linked to the colorectal cancer. Med Sci (Paris) 27: 514-520, 2011.
24. Pais R, Silaghi H, Silaghi AC, Rusu ML, Dumitrascu DL. Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol 15: 5141-5148, 2009.
25. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 434: 843-850, 2005.
26. Sayat R, Leber B, Grubac V, Wiltshire L, Persad S. O-GlcNAcglycosylation of beta-catenin regulates its nuclear localization and transcriptional activity. Exp Cell Res 314: 2774-2787, 2008.
27. Segditsas S, Tomlinson I. Colorectal cancer and genetic alterations in the Wnt pathway. Oncogene 25: 7531-7537, 2006.
28. Sethi JK, Vidal-Puig AJ. Wnt signalling at the crossroads of nutritional regulation. Biochem J 416: e11-e13, 2008.
29. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R, Ben-Zeev A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96: 5522-5527, 1999.
30. Xu W, Kimelman D. Mechanistic insights from structural studies of beta-catenin and its binding partners. J Cell Sci 120: 3337-3344, 2007.
31. Yam D, Fink A, Mashiah A, Ben-Hur E. Hyperinsulinemia in colon, stomach and breast cancer patients. Cancer Lett 104: 129-132, 1996.
32. Yang WH, Kim JE, Nam HW, Ju JW, Kim HS, Kim YS, Cho JW. Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat Cell Biol 8: 1074-1083, 2006.
33. Yang J, Zhang W, Evans PM, Chen X, He X, Liu C. Adenomatous polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination in colon cancer cells. J Biol Chem 281: 17751-17757, 2006.
34. Yang X, Ongusaha PP, Miles PD, Havstad JC, Zhang F, So WV, Kudlow JE, Michell RH, Olefsky JM, Field SJ, Evans RM. Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature 451: 964-969, 2008.
35. Zeidan Q, Hart GW. The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. J Cell Sci 123: 13-22, 2010.
36. Zhu Q, Zhou L, Yang Z, Lai M, Xie H, Wu L, Xing C, Zhang F, Zheng S. O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation. Med Oncol [Epub ahead of print], 2011.
37. Zhu W, Leber B, Andrews DW. Cytoplasmic O-glycosylation prevents cell surface transport of E-cadherin during apoptosis. EMBO J 20: 5999-6007, 2001.